Beyond Guideline-Directed Medical Therapy: Nonpharmacologic Management for Patients With Heart Failure.

cardiac rehabilitation exercise malnutrition mood disorders obesity sleep-disordered breathing sodium and fluid restriction substance use disorder

Journal

JACC. Heart failure
ISSN: 2213-1787
Titre abrégé: JACC Heart Fail
Pays: United States
ID NLM: 101598241

Informations de publication

Date de publication:
09 Oct 2024
Historique:
received: 08 05 2024
revised: 13 08 2024
accepted: 14 08 2024
medline: 25 10 2024
pubmed: 25 10 2024
entrez: 25 10 2024
Statut: aheadofprint

Résumé

Heart failure (HF) is a leading cause of cardiovascular morbidity, mortality, and health care expenditure. Guideline-directed medical therapy and device-based therapy in HF are well established. However, the role of nonpharmacologic modalities to improve HF care remains underappreciated, is underused, and requires multimodal approaches to care. Diet, exercise and cardiac rehabilitation, sleep-disordered breathing, mood disorders, and substance use disorders are potential targets to reduce morbidity and improve function of patients with HF. Addressing these factors may improve symptoms and quality of life, reduce hospitalizations, and improve mortality in heart failure. This state-of-the-art review discusses dietary interventions, exercise programs, and the management of sleep-disordered breathing, mood disorders, and substance use in individuals with heart failure. The authors review the latest data and provide optimal lifestyle recommendations and recommended prescriptions for nonpharmacologic therapies.

Identifiants

pubmed: 39453358
pii: S2213-1779(24)00624-3
doi: 10.1016/j.jchf.2024.08.018
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 American College of Cardiology Foundation. All rights reserved.

Déclaration de conflit d'intérêts

Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Auteurs

Onyedika J Ilonze (OJ)

Division of Cardiovascular Medicine, Krannert Cardiovascular Research Center, Indiana University, Indianapolis, Indiana, USA.

Daniel E Forman (DE)

Division of Geriatrics and Division of Cardiology, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA; Geriatric Research and Education Clinical Center, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA.

Lisa LeMond (L)

Cardiovascular Medicine, Mayo Clinic, Phoenix, Arizona, USA.

Jonathan Myers (J)

VA Palo Alto Health Care System, Palo Alto, California, USA; Stanford University, Palo Alto, California, USA.

Scott Hummel (S)

Department of Cardiology, University of Michigan Ann Arbor, Michigan, USA; VA Ann Arbor Health Care, Ann Arbor, Michigan, USA.

Amanda R Vest (AR)

Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Ersilia M DeFilippis (EM)

Center for Advanced Cardiac Care, Division of Cardiology, Columbia University Irving Medical Center, New York, New York, USA.

Eiad Habib (E)

Cardiovascular Medicine, Mayo Clinic, Phoenix, Arizona, USA.

Sarah J Goodlin (SJ)

Patient-Centered Education and Research, Portland, Oregon, USA; Division of Geriatrics, School of Medicine, Oregon Health and Sciences University, Portland, Oregon, USA. Electronic address: sgoodlin@patient-centered.org.

Classifications MeSH